EP3668804A1 - Infusion packets - Google Patents
Infusion packetsInfo
- Publication number
- EP3668804A1 EP3668804A1 EP18749399.4A EP18749399A EP3668804A1 EP 3668804 A1 EP3668804 A1 EP 3668804A1 EP 18749399 A EP18749399 A EP 18749399A EP 3668804 A1 EP3668804 A1 EP 3668804A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- infusion
- infusion packet
- packet
- packets
- compressed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001802 infusion Methods 0.000 title claims abstract description 247
- 235000013361 beverage Nutrition 0.000 claims abstract description 46
- 239000002243 precursor Substances 0.000 claims abstract description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 37
- 239000000463 material Substances 0.000 claims description 32
- 241001122767 Theaceae Species 0.000 claims 1
- 244000269722 Thea sinensis Species 0.000 description 51
- 235000013616 tea Nutrition 0.000 description 45
- 238000004806 packaging method and process Methods 0.000 description 13
- 238000005304 joining Methods 0.000 description 10
- 238000009517 secondary packaging Methods 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000006073 displacement reaction Methods 0.000 description 5
- 235000006468 Thea sinensis Nutrition 0.000 description 4
- 238000007373 indentation Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229910000831 Steel Inorganic materials 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000010959 steel Substances 0.000 description 3
- 238000007545 Vickers hardness test Methods 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 235000012171 hot beverage Nutrition 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 240000006914 Aspalathus linearis Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 244000107946 Spondias cytherea Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 description 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 description 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000005021 flexible packaging material Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000003116 impacting effect Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 239000012603 secondary packaging material Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
- B65D85/70—Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for
- B65D85/804—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package
- B65D85/808—Disposable containers or packages with contents which are mixed, infused or dissolved in situ, i.e. without having been previously removed from the package for immersion in the liquid to release part or all of their contents, e.g. tea bags
Definitions
- the present invention relates to infusion packets. More particularly, the present invention is directed towards infusion packets (such as tea bags) which expand to adopt a three-dimensional shape upon immersion in water.
- infusion packets such as tea bags
- infusion packets for instance tea bags
- infusible material for instance tea leaves
- infusion packets are usually packaged together in cartons for sale.
- PG Tips pyramid tea bags are sold in cartons containing 20, 40, 80, 160 or 240 tea bags.
- a drawback of providing three-dimensional infusion packets is that they have a larger volume than two dimensional packets and consequently cannot be packaged for sale as efficiently.
- EP 0 053 204 discloses a tea bag with a generally tetrahedral shape that has at least one fold permitting its collapse to a flattened configuration. A pull means affixed to the bag facilitates unfolding of the bag.
- WO 2013/174710 discloses an infusion packet comprising a gusset which is substantially flat prior to use, and can swell upon immersion in an infusion liquid such that it adopts a more three-dimensional shape.
- EP 0 846 632 discloses a liquid-permeable flexible bag body that is folded so that it can easily be accommodated in an external pack, and unfolded at the time of extraction so that the bag body has its internal space enlarged.
- the flattened (or unexpanded) format of such infusion packets is achieved by folding of the three-dimensional infusion packets in a defined manner.
- the three-dimensional shape that the infusion packets are intended to adopt when in use will inevitably influence the shape of their flattened format.
- the flattened format must be achievable via a relatively simple folding pattern.
- the expandable infusion packets described in the prior art only have a very limited number of possible configurations in their unexpanded format.
- the present invention relates to an expandable infusion packet containing a beverage precursor, wherein the infusion packet is in a permanently compressed state in the absence of water and converts to an expanded state in the presence of water, wherein the infusion packet has a density of at least 0.5 g/cm 3 when it is in the permanently compressed state, and wherein the infusion packet is substantially rigid and has a Vickers hardness (H v ) of at least 0.2 when it is in the permanently compressed state.
- H v Vickers hardness
- the present invention relates to a package comprising a plurality of expandable infusion packets according to the first aspect of the invention.
- the present invention relates to an expandable infusion packet containing a beverage precursor, wherein the infusion packet is in a permanently compressed state in the absence of water and converts to an expanded state in the presence of water, and wherein the infusion packet has a density of at least 0.5 g/cm 3 when it is in the permanently compressed state.
- the term "permanently compressed state” refers to a format which is intended to remain stable for an indefinite period of time.
- the format of the infusion packet in itself is permanently compressed, and does not convert to an expanded state in the absence of water.
- the infusion packet of the present invention does not rely on an envelope or similar secondary packaging to maintain its compressed format.
- infusion packets of the present invention When the infusion packets of the present invention are in their permanently compressed state, they cannot be unfolded simply by gently pulling or handling their constituent material. This is in contrast to infusion packets which have been folded to achieve a flattened format, which readily adopt a more expanded format on being treated in this manner, even in the absence of water.
- the infusion packets have a density of at least 0.5 g/cm 3 when they are in the permanently compressed state.
- the density of the infusion packets when they are in the permanently compressed state is at least 0.55 g/cm 3 , more preferably at least 0.6 g/cm 3 , still more preferably at least 0.65 g/cm 3 .
- the density of the infusion packets when they are in the permanently compressed state is less than 2 g/cm 3 , more preferably less than 1 .6 g/cm 3 , still more preferably less than 1.2 g/cm 3 .
- the density of the compressed infusion packets is typically greater than the bulk density of the beverage precursor. This is in contrast to the density of a standard (non- compressed) infusion packet where the density of the infusion packet will typically be less than or equal to the bulk density of the beverage precursor.
- the bulk density of the beverage precursor in its dry (i.e. uninfused) form is the mass of the beverage precursor divided by the total volume occupied.
- This bulk density is referred to herein as "uncompressed bulk density" (or p n ormai) and can be measured by filling a known mass of the beverage precursor into a measuring cylinder, tapping the cylinder several times and then measuring the volume occupied by the beverage precursor.
- the uncompressed bulk density (p n ormai) represents the bulk density of the beverage precursor in a standard infusion packet (i.e. a non-compressed infusion packet).
- the uncompressed bulk density (p n ormai) of leaf tea in its dry (uninfused) form is around 0.4 g/cm 3 .
- the bulk density of the beverage precursor contained within the infusion packet will not be the same when the infusion packet is in the permanently compressed state. In fact, the bulk density of the beverage precursor will be significantly higher when the infusion packet is in this state. In other words, a given mass of beverage precursor will occupy a smaller volume when the infusion packet is in the permanently compressed state than the volume it will occupy when the infusion packet is in the expanded state.
- the bulk density of the beverage precursor in the compressed infusion packet is referred to herein as "compressed bulk density" (or p C om ressed).
- the compressed bulk density can be determined by applying the same amount of pressure as used to make the compressed infusion packet to a known mass of the beverage precursor, and then determining the volume of the beverage precursor after the pressure has been applied (the compressed bulk density is the mass of the beverage precursor divided by the volume of the beverage precursor after the pressure has been applied).
- the compressed bulk density (p C om ressed) of the beverage precursor is greater than the uncompressed bulk density (p n ormai) of the beverage precursor by a factor of 1 .5 to 3, more preferably by a factor of 1.8 to 2.6 and most preferably by a factor of 2 to 2.4.
- the infusion packet of the present invention converts to an expanded state in the presence of water. Both hot and cold water will elicit this conversion, although (all other parameters being equal) the time taken for the infusion packet to adopt the expanded state will usually be quicker in hot water than it is in cold water. As such, the expandable infusion packet is suitable for preparing both hot and cold beverages.
- the infusion packets of the present invention When the infusion packets of the present invention are in their permanently compressed state they do not deform when handled and preferably have a substantially rigid structure. When they adopt their expanded state in the presence of water, they become deformable and preferably have a flexible structure (in other words they lose the rigidity they preferably possess in their permanently compressed state).
- the rigidity of the infusion packets in the permanently compressed state can be expressed in terms of Vickers hardness (H v ).
- the Vickers hardness number is a measure of the sample's resistance to plastic deformation.
- the Vickers hardness test is an indentation test that consists of indenting the sample with an indenter.
- the geometry of the indenter used in the Vickers hardness test is standardised (136° pyramidal diamond indenter that forms a square indent).
- the indenter is pressed into the sample by an accurately controlled test force, and then removed leaving an indent in the sample that appears square shaped on the surface.
- the infusion packets are substantially rigid and have a Vickers hardness (H v ) of at least 0.2, preferably at least 0.25, more preferably at least 0.3, and most preferably at least 0.35.
- the Vickers hardness (H v ) of the infusion packets in the compressed state is less than 1 , more preferably less than 0.9, still more preferably less than 0.8, and most preferably less than 0.75.
- the time taken for the infusion packet to convert from the compressed to the expanded state in the presence of hot water e.g. at a temperature of 90 to 100°C
- the expandable infusion packet is particularly suitable for brewing beverages which are prepared with hot water, for instance tea or herbal infusions.
- the infusion packet preferably converts from the compressed to the expanded state in a time of no more than 30 seconds, more preferably no more than 20, most preferably no more than 10 seconds.
- the expandable infusion packets are also appropriate for brewing beverages which are prepared with cold water (e.g. iced tea brewed from Lipton® Cold Brew tea bags).
- the brewing time for such beverages is typically longer than for hot beverages, for example it may be 5 minutes or longer. Therefore, rapid conversion of the infusion packet from the compressed to the expanded state is less important as far as consumer acceptance of the product is concerned.
- cold water e.g.
- the infusion packet preferably converts from the compressed to the expanded state in a time of no more than 240 seconds, more preferably no more than 180 seconds, still more preferably no more than 120 seconds and most preferably no more than 90 seconds.
- the expandable infusion packets preferably contain a beverage precursor.
- beverage precursor refers to a fabricated composition suitable for preparing a beverage.
- the beverage precursor may be contacted with an aqueous liquid such as water to provide a beverage (i.e. a substantially aqueous drinkable composition which is suitable for human consumption). This process is referred to as brewing.
- aqueous liquid such as water
- brewing This process is referred to as brewing.
- the beverage precursor typically releases certain soluble substances into the aqueous liquid, e.g. flavour and/or aroma molecules.
- the beverage precursor preferably comprises plant material, with tea and/or herb plant material being particularly preferred.
- tea plant material refers to dried leaf and/or stem material derived from Camellia sinensis (i.e. "leaf tea”).
- herb plant material refers to material which is commonly used as a precursor for herbal infusions.
- the herb plant material is selected from chamomile, cinnamon, elderflower, ginger, hibiscus, jasmine, lavender, lemongrass, mint, rooibos, rosehip, vanilla and verbena.
- the beverage precursor may additionally or alternatively comprise fruit pieces (e.g.
- the beverage precursor preferably excludes plant material which requires pressure for optimum brewing.
- the beverage precursor preferably excludes plant material derived from coffee (especially ground coffee).
- the mass of the beverage precursor is at least 1 g, as smaller amounts are difficult to accurately portion and dose. More preferably the mass is at least 1.2 g, and most preferably at least 1 .4 g. It is further preferred that the mass of the beverage precursor is less than 4 g, as larger amounts become inconvenient to store and/or handle. More preferably the mass is less than 3.5 g, and most preferably less than 3 g.
- the expandable infusion packet preferably has a first geometric shape in its permanently compressed state and a second geometric shape in its expanded state. Although it is possible for the second geometric shape to be an expanded version of the first geometric shape, it is preferred that the first and second geometric shapes are distinct.
- the infusion packet preferably has a particular geometric shape in the permanently compressed state, and converts to the expanded state wherein it adopts a different geometric shape.
- the infusion packet could have an essentially disc-shaped, cylindrical conformation in the compressed state (i.e. the first geometric shape is a cylinder), and then, on the addition of water, convert so as to have an essentially tetrahedral conformation in the expanded state (i.e. the second geometric shape is a tetrahedron).
- the first geometric shape preferably has a first face and a second face connected along a length (/.), wherein the cross-section along the length (L) is constant, and is the same shape as the first and second faces.
- the first and second face are preferably parallel to one another.
- the first geometric shape is a cylinder or a prism.
- first geometric shape is a cylinder
- first face and the second face are circular or elliptical, and are connected along the length (L) by a curved surface.
- the first face and the second face are polygonal and are connected along the length (L) by a plurality of joining faces, which are delimited from one another by a plurality of joining edges.
- the joining faces are preferably square or rectangular (i.e. the prism is preferably a right prism). Nevertheless, it will be appreciated that in a less preferred configuration the joining faces could be parallelograms (i.e. the prism could be an oblique prism).
- the first and second faces can have any simple polygonal shape (i.e. a shape wherein the boundary of the polygon does not cross itself); as such the polygonal shape can be concave or convex.
- suitable polygonal shapes include: triangles, quadrilaterals, pentagons, hexagons, heptagons, octagons, nonagons, decagons, or the like.
- the geometry and dimensions of the infusion packet in its permanently compressed state will determine how efficiently a plurality of such packets can be packaged.
- the first geometric shape preferably has a width (l l/), wherein the width (l/l/) is greater than or equal to the length (/.).
- the width (W) is the widest dimension of the first or second face in a plane which is perpendicular to the length (/.).
- the width (W) is the diameter of the circular cross-section
- the width (W) represents the major axis of the elliptical cross- section.
- the width (W) represents the diagonal of the square cross-section.
- the length (L) of the cylindrical or prismatic infusion packet in the permanently compressed state is preferably greater than 2 mm, more preferably greater than 3 mm, and most preferably greater than 4mm.
- the length (L) is preferably no more than 20 mm, more preferably no more than 18 mm, and most preferably no more than 16 mm.
- the width (W) of the cylindrical or prismatic infusion packet in the permanently compressed state is preferably greater than 14 mm, more preferably greater than 17 mm, and most preferably greater than 20 mm.
- the width (W) is preferably no more than 45 mm, more preferably no more than 40 mm, and most preferably no more than 35 mm.
- the expandable infusion packet preferably has a second geometric shape in its expanded state. As set out above, this second geometric shape is preferably a different shape to the first geometric shape.
- an embodiment wherein the second geometric shape is essentially flat e.g. an infusion packet comprising infusible material sandwiched between square or round sheets of porous material
- an embodiment is less preferred, since infusion packets of this type are believed to restrict the movement of the infusible material to substantially two dimensions, thereby limiting their infusion performance.
- packaging a plurality of this type of infusion packets is already relatively efficient due to their essentially flat nature.
- the second geometric shape is a three-dimensional shape.
- the second geometric shape can be any three-dimensional shape.
- infusion packets having the second geometric shape can be readily manufactured on a large-scale.
- preferred examples of the second geometric shape include shapes such as tetrahedral, pyramidal, hemispherical, spherical, cubic, and the like. It is particularly preferred that the second geometric shape is a sphere, a hemisphere, a tetrahedron or a pyramid.
- the present invention envisages compressing conventional infusion packets so as to achieve a format wherein the infusion packets are in a permanently compressed state.
- conventional infusion packets include spherical or hemispherical infusion packets such as those described in EP 081 1562 (Unilever), WO 2012/095247 (Unilever) or WO 2005/051797 (Tetley), and tetrahedral-shaped infusion packets such as those described in WO 95/01907 (Unilever), WO 2004/033303 (I.M.A. SPA), or WO 2012/004169 (Unilever).
- the expandable infusion packet preferably has a first geometric shape in its permanently compressed state and a second geometric shape in its expanded state.
- the second geometric shape is an expanded version of the first geometric shape, it is preferred that the first and second geometric shapes are distinct.
- the infusion packet preferably has a particular geometric shape in the permanently compressed state, and converts to the expanded state wherein it has a different geometric shape.
- the expandable infusion packet has a volume Vc in the permanently compressed state and a volume VE in the expanded state.
- Vc in the permanently compressed state
- VE in the expanded state.
- VE is preferably at least 2Vc, more preferably at least 2.5Vc, and most preferably at least 3Vc.
- the expandable infusion packet should be able to convert from its permanently compressed state to its expanded state in an efficient manner on the addition of water.
- VE is preferably no more than 10Vc, more preferably no more than 8Vc, and most preferably no more than 6Vc.
- the expandable infusion packet of the present invention can be made from any suitable material.
- Non-woven materials are particularly preferred, since these materials typically have relatively little "memory" in the fibres, and therefore readily convert from the compressed state to the expanded state on the addition of water.
- Non-limiting examples of non-woven materials include non-woven materials made with continuous filaments (e.g. PET, PLA, PP) and wet laid non-woven materials (e.g. cellulose/polymer blends comprising cellulose and polymers such as PP, PE, or PLA).
- the invention in a second aspect, relates to a package comprising a plurality of expandable infusion packets according to the first aspect of the invention.
- the geometry of the expandable infusion packet in its permanently compressed state will determine how efficiently a plurality of such packets can be packaged. Nevertheless, the infusion packets of the present invention will require less storage space in their compressed state than in their expanded state, regardless of the particular geometry chosen.
- the format of the package is not limited. For cost reasons, it is preferred that the package chosen is not overly complicated to manufacture. From the standpoint of simplicity, it is preferred that the package is a tube or a carton. A further benefit of such packaging solutions is that the packaged product only requires a small amount of storage space in the consumer's home. Indeed, it is preferred that the secondary packaging is sufficiently compact that the infusion packets can be conveniently carried around by the consumer or kept at work.
- tubular packages examples include cardboard, plastic, or metallic tubes having an appropriately shaped cross-section.
- a hollow tube having a triangular cross-section could efficiently package a plurality of such infusion packets.
- the tubular package could be formed around the compressed infusion packets.
- a plurality of compressed infusion packets could be arranged in a stack, and packaged in a tubular manner by way of a sheet of flexible packaging material (e.g. paper or plastic) being wrapped around the stacked infusion packets in a circumferential manner and sealed where the edges of the sheet meet (i.e.
- the package is a tube and the first geometric shape is a cylinder (i.e. the expandable infusion packet has an essentially disc-shaped, cylindrical conformation in the permanently compressed state).
- the tube does not need to have the same cross-section as the expandable infusion packet.
- the tube may have a circular or elliptical cross-section and hence match the cross-section of the first geometric shape.
- the tube may have a cross-section which does not match that of the first geometric shape.
- the space between the infusion packet and the tube in such an embodiment is believed to facilitate removal of the infusion packet from the carton (by allowing the consumer to easily grip the curved surface of the infusion packet).
- a tube with a square or rectangular cross-section is particularly preferred, since such cartons are easily manufactured.
- an expandable infusion packet wherein the first geometric shape is a hexagonal prism could be packaged in a tube having a square cross-section, etc.
- the secondary packaging can be a carton.
- the tubular format described above relates to a packaging solution for a stack of compressed infusion packets.
- a carton provides a solution for packaging layers or rows of the compressed infusion packets (wherein each layer or row comprises two or more compressed infusion packets). It is possible to package compressed infusion packets in this manner regardless of the first geometric shape of such infusion packets. For maximum packaging efficiency, it is preferred that the first geometric shape tessalates.
- the package is a carton and the first geometric shape is a square or rectangular prism (i.e. the expandable infusion packet has a prismatic conformation with a square or rectangular cross-section in the permanently compressed state).
- the package is a carton and the first geometric shape is a cylinder (i.e. the expandable infusion packet has an essentially disc-shapes, cylindrical conformation in the permanently compressed state).
- a carton with a square or rectangular cross-section is particularly preferred, since such cartons are easily manufactured.
- the space between the rows of infusion packets and the carton is believed to facilitate removal of the infusion packet from the carton (by allowing the consumer to easily grip the curved surface of the infusion packet).
- the present invention envisages compressing conventional infusion packets so as to achieve a format wherein the infusion packets are in a permanently compressed state.
- This can be achieved by a method comprising the steps of (a) providing an infusion packet in an expanded state; (b) inserting the infusion packet in a die; and (c) applying pressure so as to convert the infusion packet to a permanently compressed state.
- the infusion packet provided in step (a) is preferably a conventional infusion packet, and can be manufactured by any known method. Tetrahedral-shaped infusion packets are particularly preferred.
- the infusion packet provided in step (a) is inserted into a die.
- the die is metallic, for example it can conveniently be made of steel.
- the pressure applied in step (c) is preferably applied via a piston which fits in the die.
- the piston is metallic, for example it can conveniently be made of aluminium.
- the dies and the piston are preferably made from different metals. Factors which influence the appropriate pressure applied in step (c) include the area of the cross- section of the die used in step (b), the type of material the infusion packet is made from and the size/weight of the infusion packet.
- the pressure applied in step (c) will typically be higher where a greater degree of compression is desired, and lower where a smaller degree of compression is desired.
- the amount of infusible material contained within the infusion packet has a given volume (e.g. the volume occupied by 3 g of infusible material will be greater than that occupied by 2 g of infusible material).
- the more infusible material contained within the infusion packet the greater the volume occupied by that infusible material.
- infusion packets comprising higher amounts of infusible material will typically be compressed to a lesser degree than infusion packets comprising lower amounts of infusible material.
- Figure 1 a is a perspective view of an expandable infusion packet in a permanently compressed state
- Figure 1 b is a perspective view of the expandable infusion packet of Figure 1 a in an expanded state
- Figure 2a is a perspective view of a compressed infusion packet according to the invention which has been placed in a receptacle ready for brewing;
- Figure 2b is a representation of the infusion packet of Figure 2a once water has been added to the receptacle so as to prepare a beverage;
- Figure 3a is a perspective view showing an arrangement of a plurality of compressed infusion packets
- Figure 3b is a perspective view showing one embodiment of a package comprising a plurality of compressed infusion packets
- Figure 3c is a perspective view showing an alternative embodiment of a package comprising a plurality of compressed infusion packets
- Figure 4 shows a series of perspective views illustrating possible shapes for expandable infusion bags according to the present invention in their permanently compressed state.
- Figure 5a is a perspective view of an infusion packet with a hemispherical expanded state;
- Figure 5b is a perspective view of an infusion packet with a cubic expanded state
- Figure 6 is a perspective view showing a carton comprising a plurality of compressed infusion packets
- Figure 7 illustrates different arrangements a plurality of compressed infusion packets
- Figure 8 is a perspective view showing a carton comprising a plurality of compressed infusion packets.
- Figure 1 a shows an expandable infusion packet according to the invention in its permanently compressed state.
- the compressed infusion packet (1 ) is cylindrical and has a circular cross-section.
- the infusion packet has a circular first face (2) and circular second face (which is opposite the first face, and thus not visible in Figure 1 a) connected along a length (L) by a curved surface (4).
- the cross-section along the length (L) is constant, and is the same shape as the first and second faces (i.e. circular).
- the width (W) is the diameter of the circular cross-section.
- Figure 1 b shows the infusion packet of Figure 1 a in its expanded state.
- the expanded infusion packet (5) has adopted a three-dimensional tetrahedral shape. As such, the infusion packet has a different shape in its expanded state than it had in its compressed state.
- the three-dimensional expanded state allows the infusible material (6) room to move within the infusion packet (5), which is believed to improve infusion performance.
- Figure 2 illustrates the conversion of an expandable infusion packet according to the present invention from its permanently compressed state to its expanded state. This conversion occurs under the conditions typically used by a consumer to prepare an infusion from a conventional infusion packet.
- Figure 2a shows the infusion packet prior to the start of brewing.
- the compressed infusion packet (1 ) has been placed in a receptacle (7) which is suitable for receiving a quantity of hot water (in this case a mug).
- a quantity of hot water in this case a mug.
- the infusion packet converts to an expanded state in the presence of water (8).
- the volume of water used by consumers to prepare a beverage from a conventional infusion packet varies, and is not constant from one geography to another.
- the volume of water that will cause the infusion packet to convert from its permanently compressed state to its expanded state is not very large, although it will be appreciated that this volume is typically greater than VE (100 ml of water will usually be sufficient).
- Figure 2b shows the infusion packet during brewing. The infusion packet is now in its expanded state (5), and has adopted a three-dimensional tetrahedral shape.
- the compressed infusion packets of the present invention can be conveniently packaged.
- Figure 3a shows a plurality of compressed infusion packets (1 ), which have been stacked one on top of the other. Since the infusion packets have a regular shape in the compressed state, this arrangement results in a format with a constant cross-section (in this case, a circular cross-section).
- Figure 3b shows a possible way of packaging a plurality of compressed infusion packets (1 ).
- the stack of expandable infusion packets is kept together by secondary packaging (9).
- this secondary packaging (9) is tubular and takes the form of a sheet (e.g. formed of paper or plastic) which extends around the infusion packets in a circumferential manner and is sealed where its edges meet.
- Figure 3c shows an alternative way of packaging a plurality of compressed infusion packets (1 ).
- the secondary packaging (9) is a cardboard tube having a square cross-section. This carton has the form of a square prism.
- the compressed infusion packets do not fill the entire volume of the carton, the packaging efficiency is still improved (i.e. a carton designed to accommodate an equivalent number of conventional infusion packets having an expanded format would have a significantly larger volume).
- the compressed infusion packet has the form of a triangular prism.
- the first and second faces of the infusion packet are triangular, and are connected along the length (L) by three rectangular joining faces (11 ), which are delimited from one another by three joining edges (12).
- the width (W) is the distance between two adjacent vertices of the triangular cross-section.
- the compressed infusion packet is a square prism.
- the first and second faces of the infusion packet are square, and are connected along the length (L) by four rectangular joining faces (11 ), which are delimited from one another by four joining edges (12).
- the width (W) is the diagonal of the square cross- section.
- Figures 4c and 4d illustrate two possible hexagonal prism configurations for the compressed infusion packet.
- the first and second faces of the infusion packet are hexagonal, and are connected along the length (L) by six rectangular joining faces (11 ), which are delimited from one another by six joining edges (12).
- the compressed infusion packet of Figure 4c has a convex hexagonal cross-section
- the compressed infusion packet of 4d has an L-shaped concave hexagonal cross-section.
- the shape of the expandable infusion packet in its expanded state is not limited, and can be any geometric shape.
- Figure 5 shows some possible configurations.
- the expanded infusion packet (5) has a three-dimensional hemispherical shape, whilst in Figure 5b it has a cubic shape in its expanded form. It will be appreciated that there is no particular link between the shape of the expandable infusion packet in its compressed state and in its expanded shape.
- an infusion packet having any one of the expanded shapes shown in Figures 1 b, 5a and 5b can be compressed so as to have any one of the configurations shown in Figures 1 a, 4a, 4b, 4c and 4d.
- the shape of the infusion packet in its compressed state could be used as a code help consumers identify the appropriate product.
- a range of products are often sold by a particular manufacturer (such as green tea, black tea, fruit and herbal infusions, etc.).
- each member of the range uses the same shaped infusion packet (e.g. tetrahedral).
- Each type of product is sold in a separate package (e.g. a carton containing a certain number of infusion packets), and the information provided on the package identifies the particular product type.
- the present invention allows each product in the range to have a different shape in the permanently compressed state (whilst still maintaining a common shape in the expanded state).
- infusion packets containing black tea could have the form of a cylinder, whilst those containing green tea could have the form of a hexagonal prism, and so on. In this way, even if the compressed infusion packets had been removed from the package in which they were sold, the consumer would still be able to visually identify each product in the range.
- Figure 6 shows a possible way of packaging a plurality of compressed infusion packets.
- a number of compressed infusion packets (1 ) are arranged inside a cardboard carton (15).
- the square cross-section of the infusion packets (1 ) means that they tessalate, thus resulting in a very efficient use of the internal space within the carton.
- Figure 7 illustrates different arrangements a plurality of compressed infusion packets.
- Figure 7a shows a plurality of compressed infusion packets (1 ) having a hexagonal cross-section which have been stacked one on top of the other.
- the regular shape of these infusion packets in the compressed state means that the stack of infusion packets has a constant cross-section.
- the stack of expandable infusion packets can be packaged so as to maintain this arrangement (e.g. in a similar manner to that illustrated for in Figure 3b).
- Figure 7b shows an alternative arrangement of compressed infusion packets (1 ) having a hexagonal cross-section.
- the compressed infusion packets are arranged in a single layer.
- the regular hexagonal cross-section of the infusion packets (1 ) means that they tessalate.
- the layer of expandable infusion packets can be packaged so as to maintain this arrangement (e.g. by packaging them in a cardboard carton).
- Figure 8 shows a possible way of packaging a plurality of compressed infusion packets.
- a number of compressed infusion packets (1 ) are arranged inside a cardboard carton (15).
- the circular cross-section of the infusion packets (1 ) means that they do not tessalate. Nevertheless, the compressed infusion packets are still very efficiently packaged, whilst the small amount of space around the compressed infusion packets allows the consumer to easily remove an individual infusion packet by gripping the curved surface thereof.
- the final packaging arrangement could comprise multiple layers of the compressed infusion packets. Indeed, it is also envisaged that each layer of infusion packets could have a different shape in the compressed format. For example, a first layer could consist of infusion packets having a hexagonal cross-section, with a second layer consisting of infusion packets having a square cross-section. Examples
- a commercially available PG Tips pyramid tea bag (bag weight 2.9 g) was provided.
- the shape of this tea bag in the expanded state was essentially tetrahedral (edge length 65 mm).
- the volume of the tea bag in the expanded state (VE) was 32365 mm 3 .
- the tea bag was inserted into a steel die having the form of a hollow cylinder and converted into a permanently compressed state by applying 4200 kPa pressure via an aluminium piston that slides within the cylindrical die thereby compressing the tea bag.
- the shape of this tea bag in the permanently compressed state was essentially cylindrical (with a circular cross-section).
- the width (W) of the compressed cylindrical format of the tea bag was 32 mm, and the length (L) was 5 mm.
- the volume of the tea bag in the permanently compressed state was 4021 mm 3 .
- the density of the tea bag in the permanently compressed state was calculated to be 0.72 g/cm 3 .
- the Vickers hardness (H v ) of a permanently compressed tea bag was determined. Measurements were conducted on an Instron universal testing machine (type 5500R) running Bluehill2TM software (version 2.17). The sample was positioned on the base plate and indenter lowered manually until it was close to the sample surface. A pre- loading cycle was run with a displacement of 1 mm/min until a load of 0.1 N was measured, at which point an autocalibration for displacement and load was made.
- the loading cycle was run at a displacement of 2 mm/min until the tip of the indenter was pushed into the sample to a depth of 2.5 mm.
- the unloading cycle was run at a displacement of 2 mm/min until the load had returned to zero.
- the permanently compressed tea bag had a Vickers hardness H v of 0.46.
- the permanently compressed tea bag was placed in an empty cup, and 200 ml of hot water was added.
- the tea bag converted to its expanded form in a matter of seconds. Moreover, this conversion caused the tea bag to "tumble". This movement facilitates rapid brewing of the tea leaves contained within the tea bag without the need for stirring or otherwise agitating the tea bag.
- PG Tips pyramid tea bag bag weight 2.9 g
- 200 ml of hot water was added.
- the addition of the water caused temporary flattening of the tea bag.
- the tea bag floated once addition of the water was completed it did not "tumble" and was essentially static during brewing. The lack of movement meant that the tea leaves contained within the tea bag did not brew as rapidly.
- the bulk density of the leaf tea blend contained within the PG Tips pyramid tea bag in the expanded (or non-compressed) state was determined to be 0.46 g/cm 3 .
- the bulk density of the leaf tea blend in the compressed state was estimated to be 0.97 g/cm 3 . This was determined by placing a known mass of the leaf tea blend in the same steel die used to make the compressed tea bag, applying 4200 kPa pressure to the leaf tea blend and then calculating the volume of the leaf tea after the pressure had been applied. It can be seen that the bulk density of the leaf tea in the compressed tea bag is significantly higher than that of the leaf tea in the expanded (non-compressed) tea bag.
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Packages (AREA)
- Tea And Coffee (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL18749399T PL3668804T3 (en) | 2017-08-16 | 2018-08-09 | Infusion packets |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17186362 | 2017-08-16 | ||
PCT/EP2018/071647 WO2019034531A1 (en) | 2017-08-16 | 2018-08-09 | Infusion packets |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3668804A1 true EP3668804A1 (en) | 2020-06-24 |
EP3668804B1 EP3668804B1 (en) | 2021-10-20 |
Family
ID=59649527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18749399.4A Active EP3668804B1 (en) | 2017-08-16 | 2018-08-09 | Infusion packets |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3668804B1 (en) |
JP (1) | JP7210546B2 (en) |
CN (1) | CN111315668B (en) |
EA (1) | EA038770B1 (en) |
PL (1) | PL3668804T3 (en) |
WO (1) | WO2019034531A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4329522A1 (en) * | 2021-04-30 | 2024-03-06 | Nicoventures Trading Limited | Oral products with high-density load |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2529429C3 (en) * | 1975-07-02 | 1978-07-20 | Adolf 4005 Meerbusch Rambold | Infusion bags and methods of packaging infusion bags |
EP0053204B1 (en) | 1980-11-14 | 1985-08-21 | Unilever N.V. | Infusion package and method of forming it |
DE3307046A1 (en) * | 1983-02-28 | 1984-08-30 | Erich 6053 Obertshausen Emge | Filter bag containing finely ground coffee, for a quick cup of coffee |
JP2575586Y2 (en) * | 1991-03-29 | 1998-07-02 | 章 日名 | Container with lysate |
GB9314098D0 (en) | 1993-07-08 | 1993-08-18 | Unilever Plc | Apparatus and methods for producing packets |
DE69612482T2 (en) | 1996-06-04 | 2001-07-26 | Unilever N.V., Rotterdam | Tea bags |
JP3956019B2 (en) * | 1996-12-06 | 2007-08-08 | 不双産業株式会社 | Package |
DE69728739T2 (en) | 1996-12-06 | 2005-03-31 | Fuso Sangyo K.K. | Flexible and permeable container with a trailer |
DE29621889U1 (en) * | 1996-12-17 | 1997-02-13 | Holthoff, Martin, 47652 Weeze | Tea bags for the preparation of a coffee beverage |
JP3088479U (en) | 2002-03-08 | 2002-09-13 | 呉丁旺 | Tea bag |
CN2568585Y (en) * | 2002-08-05 | 2003-08-27 | 向明炎 | Triangular pyramid bagged tea |
ITBO20020638A1 (en) | 2002-10-09 | 2004-04-10 | I M A Ind Macchine Automatich E S P A | PACKAGING MACHINE, AND ITS OPERATING METHOD, |
GB0327299D0 (en) | 2003-11-24 | 2003-12-24 | Tetley Gb Ltd | Infusion packages |
CN102971218B (en) | 2010-07-07 | 2014-10-01 | 荷兰联合利华有限公司 | Process and apparatus for producing packets |
JP5944411B2 (en) | 2011-01-12 | 2016-07-05 | ユニリーバー・ナームローゼ・ベンノートシヤープ | How to make a leached parcel |
EA031046B1 (en) | 2012-05-22 | 2018-11-30 | Юнилевер Н.В. | Infusion packet and method of manufacturing same |
JP2015008762A (en) | 2013-06-26 | 2015-01-19 | ▲曽▼沂濱 | Joint-type folding envelope structure for poured and soaked object |
CN205250266U (en) * | 2015-12-03 | 2016-05-25 | 张天才 | Tea bag of cold bubble camellia |
-
2018
- 2018-08-09 EA EA202090188A patent/EA038770B1/en unknown
- 2018-08-09 JP JP2020507536A patent/JP7210546B2/en active Active
- 2018-08-09 CN CN201880067151.5A patent/CN111315668B/en active Active
- 2018-08-09 EP EP18749399.4A patent/EP3668804B1/en active Active
- 2018-08-09 PL PL18749399T patent/PL3668804T3/en unknown
- 2018-08-09 WO PCT/EP2018/071647 patent/WO2019034531A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA038770B1 (en) | 2021-10-18 |
WO2019034531A1 (en) | 2019-02-21 |
CN111315668B (en) | 2021-10-22 |
PL3668804T3 (en) | 2022-02-07 |
EA202090188A1 (en) | 2020-07-20 |
EP3668804B1 (en) | 2021-10-20 |
JP7210546B2 (en) | 2023-01-23 |
CN111315668A (en) | 2020-06-19 |
JP2020531371A (en) | 2020-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI90307C (en) | Device for extraction of beverage | |
TW575413B (en) | Filter device for coffee or the like | |
CA1115246A (en) | Foldable cup | |
CN107249989A (en) | The volume product that can be shaped again of the hollow centreless of compression | |
AU2017217607B2 (en) | Infusion packets | |
EP3668804B1 (en) | Infusion packets | |
CN107406188A (en) | Packaged food and the method for producing packaged food | |
US20150251843A1 (en) | Packages for bedding products including mattresses and mattress toppers | |
RU2598837C2 (en) | Package for beverage preparation | |
US20070131120A1 (en) | Infuser assembly for preparing beverage in container with narrow opening | |
US6274180B1 (en) | Expandable beverage infusion device | |
US20030170345A1 (en) | Structure of a tea bag | |
KR20100053883A (en) | Stick type tea bag | |
EP0053204A1 (en) | Infusion package and method of forming it | |
WO2008057005A1 (en) | Package for expendable substances | |
US20230232855A1 (en) | Biodegradable and Dissolvable Consumable Pod and a Method of Preparing an Instant Consumable | |
WO1996023713A1 (en) | A disposable packaging for the production of beverages especially tea, and a method for production of such packaging | |
CN212474264U (en) | Carton with multiple containing cavities | |
JP3011247U (en) | Dripper container | |
CN210643555U (en) | Tea tray and tea bag | |
KR101300588B1 (en) | Packaging body having built-in stick | |
WO2011091049A1 (en) | Method and apparatus for a disposable cup | |
JP2007055618A (en) | Extraction pack | |
JPH0671470U (en) | Tea pack | |
AU2002254679A1 (en) | Invertible food container |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200212 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: UNILEVER PLC Owner name: UNILEVER IP HOLDINGS B.V. |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20210520 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: UNILEVER IP HOLDINGS B.V. Owner name: UNILEVER PLC |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602018025344 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1439776 Country of ref document: AT Kind code of ref document: T Effective date: 20211115 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20211020 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1439776 Country of ref document: AT Kind code of ref document: T Effective date: 20211020 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220120 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: EKATERRA RESEARCH AND DEVELOPMENT UK LIMITED |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602018025344 Country of ref document: DE Owner name: EKATERRA RESEARCH AND DEVELOPMENT UK LIMITED, GB Free format text: FORMER OWNER: UNILEVER IP HOLDINGS B.V., ROTTERDAM, NL Ref country code: DE Ref legal event code: R082 Ref document number: 602018025344 Country of ref document: DE Representative=s name: MEWBURN ELLIS LLP, DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220220 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220221 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220120 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220121 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602018025344 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20220721 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220809 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220831 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220831 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20220831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220809 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220831 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20230719 Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20180809 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211020 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240715 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240719 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240718 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PL Payment date: 20240709 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20240827 Year of fee payment: 7 |